Modulation of the T cell compartment by blood transfusion: Effect on cytotoxic and helper T lymphocyte precursor frequencies and T cell receptor Vβ usage

Transplantation

Volumn 63, Issue 8, 1997, Pages 1145-1154

  Van Der Mast, Barbara J ^a   Viëtor, Henk E ^a   Van Der Meer Prins, Ellen M W ^a   Van Bree, Simone P M J ^a   Brand, Anneke ^a   Van Den Elsen, Peter J ^a   Claas, Frans H J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DR ANTIGEN; T LYMPHOCYTE RECEPTOR;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ERYTHROCYTE CONCENTRATE; FEMALE; HELPER CELL; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; MALE; PRIORITY JOURNAL; PROLYMPHOCYTE; RECIPIENT; T LYMPHOCYTE ACTIVATION;

EID: 17044446452     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199704270-00015     Document Type: Article

References (51)

1. Opelz G, Sengar DPS, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5: 253.
2. Persijn GG, Cohen B, Lansbergen Q, van Rood JJ. Retrospective and prospective studies on the effect of blood transfusions in renal transplantation in The Netherlands. Transplantation 1979; 28: 396.
3. Lundgren G, Groth CG, Albrechtsen D, et al. HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation: a changing picture with cyclosporin. Lancet 1986; 2: 66.
4. Opelz G. The role of HLA matching and blood transfusions in the cyclosporine era. Collaborative Transplant Study. Transplant Proc 1989; 21: 609.
5. Opelz G. Improved kidney graft survival in nontransfused recipients. Transplant Proc 1987; 19: 149.
6. Melzer JS, Husing RM, Feduska NJ, et al. The beneficial effect of pretransplant blood transfusions in cyclosporine-treated cadaver renal allograft recipients. Transplantation 1987; 43: 61.
7. Terasaki PI. The beneficial transfusion effect on kidney graft survival attributed to clonal deletion [Review]. Transplantation 1984; 37: 119.
8. Hutchinson IV. Suppressor T cells in allogeneic models [Review]. Transplantation 1986; 41: 547.
9. Rammensee HG. Veto function in vitro and in vivo [Review]. Int Rev Immunol 1989; 4: 175.
10. Van Rood JJ, Claas FH. The influence of allogeneic cells on the human T and B cell repertoire. Science 1990; 248: 1388.
11. Reed E, Hardy M, Benvenisty A, et al. Effect of anti-idiotypic antibodies to HLA on graft survival in renal-allograft recipients. N Engl J Med 1987; 316: 1450.
12. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989; 169: 493.
13. De Waal LP, van Twuyver E. Blood transfusion and allograft survival: is mixed chimerism the solution for tolerance induction in clinical transplantation? [Review.] Crit Rev Immunol 1991; 10: 417.
14. Lagaaij EL, Hennemann IP, Ruigrok M, et al. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med 1989; 321: 701.
15. Middleton D, Martin J, Douglas J, McClelland M. Transfusion of one HLA-DR antigen-matched blood to potential recipients of a renal allograft. Transplantation 1994; 58: 845.
16. Bayle F, Masson D, Zaoui P, et al. Beneficial effect of one HLA haplo- or semi-identical transfusion versus three untyped blood units on alloimmunization and acute rejection episodes in first renal allograft recipients. Transplantation 1995; 59: 719.
17. 16a. van der Mast BJ, Balk AHMM. The effect of HLA-DR shared blood transfusion on the clinical outcome of heart transplantation. Transplantation (in press).
18. van Twuyver E, Mooijaart RJ, ten Berge IJ, et al. Pretransplantation blood transfusion revisited. N Engl J Med 1991; 325: 1210.
19. van Twuyver E, Mooijaart RJ, ten Berge IJ, et al. High-affinity cytotoxic T lymphocytes after non-HLA-sharing blood transfusion: the other side of the coin. Transplantation 1994; 57: 1246.
20. Munson JL, van Twuyver E, Mooijaart RJ, Roux E, ten Berge IJ, de Waal LP. Missing T-cell receptor V beta families following blood transfusion: the role of HLA in development of immunization and tolerance. Hum Immunol 1995; 42: 43.
21. Hawes GE, Struyk L, van den Elsen PJ. Differential usage of T cell receptor V gene segments in CD4+ and CD8+ subsets of T lymphocytes in monozygotic twins. J Immunol 1993; 150 : 2033.
22. Davey MP, Meyer MM, Munkirs DD, Babcock D, Braun MP, Hayden JB. T-cell receptor variable beta genes show differential expression in CD4 and CD8 T cells. Hum Immunol 1991; 32: 194.
23. Sharrock CEM, Kaminski E, Man S. Limiting dilution analysis of human T cells: a useful clinical tool. Immunol Today 1990; 11: 281.
24. Bouma GJ, van der Meer-Prins PM, van Bree FP, van Rood JJ, Claas FH. Determination of cytotoxic T-lymphocyte precursor frequencies using europium labeling as a nonradioactive alternative to labeling with chromium-51. Hum Immunol 1992; 35: 85.
25. Roelen D, Datema G, van Bree S, Zhang L, van Rood J, Claas F. Evidence that antibody formation against a certain HLA alloantigen is associated not with a quantitative but with a qualitative change in the cytotoxic T cells recognizing the same antigen. Transplantation 1992; 53: 899.
26. Malissen B, Rebai N, Liabeuf A, Mawas C. Human cytotoxic cell structures associated with expression of cytolysis: I. Analysis at the clonal cell level of the cytolysis-inhibiting effect to monoclonal antibodies. Eur J Immunol 1982; 12: 739.
27. Moretta A, Pantaleo G, Mingari MC, Cerotinni JC. Clonal heterogeneity in the requirement for T3, T4 and T8 molecules in human cytolytic lymphocyte function. J Exp Med 1984; 159: 921.
28. Bouma GJ, Schanz U, Oudshoorn M, et al. A cell-saving non-radioactive limiting dilution analysis assay for the combined determination of helper and cytotoxic T lymphocyte precursor frequencies. Bone Marrow Transplant 1996; 17: 19.
29. Schanz U, Roelen DL, Bruning JW, Kardol MJ, van Rood JJ, Claas FH. The relative radioresistance of interleukin-2 production by human peripheral blood lymphocytes: consequences for the development of a new limiting dilution assay for the enumeration of helper T lymphocyte precursor frequencies. J Immunol Methods 1994; 169: 221.
30. Heeg K, Steeg C, Wagner H. High-dose irradiated splenic stimulator cells show no endogenous interleukin-2 production but stimulate clonally developing helper T cells to produce interleukin-2. J Immunol Methods 1988; 109: 185.
31. Lin Y, Langman R, Cohn M. The priming of cytotoxic T-cell precursors is strictly helper T-cell dependent. Scand J Immunol 1992; 35: 621.
32. Struyk L, Kurnick JT, Hawes GE, et al. T-cell receptor V-gene usage in synovial fluid lymphocytes of patients with chronic arthritis. Hum Immunol 1993; 37: 237.
33. Strijbosch LWG, Buurman WA, Does RJM, Zinken P, Groenewegen G. Limiting dilution assays: experimental design and statistical analysis. J Immunol Methods 1987; 97: 133.
34. Vandekerckhove BA, Datema G, Zantvoort F, Claas FH. An increase of donor-specific T helper precursors resulting from blood transfusions. Transplantation 1990; 45: 987.
35. Vandekerckhove BA, van Bree S, Zhang L, Datema G, Zantvoort F, Claas FH. Increase of donor-specific cytotoxic T lymphocyte precursors after transfusion. Transplantation 1989; 48: 672.
36. van Prooijen HC, Aarts-Riemens MI, Van Oostendorp WR, Hené RJ, Gmelig-Meyling FHJ, De Weger RA. Prevention of donor-specific T-cell unresponsiveness after buffy-coat-depleted blood transfusion. Br J Haematol 1995; 91: 219.
37. Persijn GG, Hendriks GF, van Rood JJ. HLA matching, blood transfusion and renal transplantation. Clin Immunol Allergy 1984; 4: 535.
38. Light JA, Metz S, Oddenino K, et al. Fresh versus stored blood in donor-specific transfusion. Transplant Proc 1982; 14: 296.
39. Mincheff MS, Meryman HT. Blood transfusion, blood storage and immunomodulation [Review]. Immunol Invest 1995; 24: 303.
40. Hawes GE, van den Elsen PJ. T cell receptor usage in alloreactivity. London: Landes Company, 1995: 63.
41. Hand SL, Hall BL, Finn OJ. T cell receptor V beta gene usage in HLA-DR1-reactive human T cell populations: the predominance of V beta 8. Transplantation 1992; 54: 357.
42. Hanto DW, Ruger JK, Rossi SJ. Alloresponses in vitro and in vivo show restricted T-cell receptor V beta gene usage. Transplant Proc 1995; 27: 491.
43. Kotb M, Lobashevsky A, Guedez Y, et al. Restricted V beta usage by alloreactive T cells responding to specific HLA-DR alleles. Transplant Proc 1995; 27: 477.
44. Barth C, Pavlakis M, Lavery P, Strom TB, Loertscher R. Restricted TCR V beta repertoire in the human mixed lymphocyte reaction is determined by the TCR on the responder cell and not by the stimulating antigen on the stimulator cell. Transplantation 1996; 61: 133.
45. Carlquist JF, Hammond ME, Yowell RL, Holland C, Swanson S, Anderson JL. Correlation between cellular rejection of cardiac allografts and quantitative changes among T-cell subsets identified by Vb epitope expression. Circulation 1994; 90: 686.
46. Malhotra U, Spielman R, Concannon P. Variability in T cell receptor VB gene usage in human peripheral blood lymphocytes. J Immunol 1992; 149: 1802.
47. Cossarizza A, Ortolani C, Mussini C, et al. Lack of selective V beta deletion in CD4+ or CD8+ T lymphocytes and functional integrity of T-cell repertoire during acute HIV syndrome. AIDS 1995; 9: 547.
48. Grunewald J, Jeddi-Tehrani M, Dersimonian H, Andersson R, Wigzell H. A persistent T cell expansion in the peripheral blood of a normal adult male: a new clinical entity? Clin Exp Immunol 1992; 89: 279.
49. Lobo-Yeo A, Lamb JR. Superantigens as immunogens and tolerogens. Clin Exp Rheumatol 1993; 11 (suppl 8): S17.
50. Scully R, Qin S, Cobbold S, Waldmann H. Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells. Eur J Immunol 1994; 24: 2383.
51. Sharrock CEM, Man S, Wanachiwanawin W, Batchelor JR. Analysis of the alloreactive T cell responses against allogeneic MHC molecules in unrelated individuals. Transplantation 1987; 43: 699.